LOS ANGELES — Stem-cell treatments are set to increase across the United States, in the wake of a federal court ruling that dealt a severe blow to the FDA’s ability to regulate such treatments.
After a years-long legal battle, a federal court in Riverside, California ruled in August against the U.S. Food and Drug Administration in its lawsuit against the Cell Surgical Network, an organization that provides stem cell treatments to patients.
